GJC2 and myeloid sarcoma: Oligodendrocytic Cx47 and Cx32 are persistently lost in acute and chronic MS plaques, while astrocytic Cx43 is lost in acute lesions and then upregulated in chronic astrogliotic plaques (22–24).